Opthea : Angiogenesis 2022 -Prof Cheung presentation of PCV

OPT-302 Combination Therapy in onlyPolypoidal Choroidal Vasculopathy


useGemmy Cheung MBBS, FRCOphth, FAMS, MCI


Head and Senior Consultant,
... | February 13, 2022

Related Keywords

, Opthea Group , Exchange Commission , Opthea Or Company , Opthea Limited , Opthea Limited Stock Exchange , News , Information , Press Release , Combination , Therapy , N , Nlypolypoidal , Horoidal , Segemmy , Cheung , Head , End , Enior Opt Au000000opt2 ,